|
Gene symbol |
Gene Name |
Disease |
ER |
ARSE |
Arylsulfatse E |
Chondrodysplasia punctata X-linked recessive [MIM 302950] |
|
ATL1 |
Atlastin 1 |
Neuropathy, hereditary sensory, type ID [MIM 613708] |
|
CLN6 |
Ceroid lipofuscinosis, neuronal, 6 |
Ceoid lipofuscinosis 6 [MIM 601780] |
|
CLN8 |
Ceroid lipofuscinosis, neuronal, 8 |
Ceoid lipofuscinosis 8 [MIM 600143] |
|
CRTAP |
cartilage associated protein |
Osteogenesis imperfecta,[MIM 610682] |
|
DHCR7 |
7-dehydrocholesterol reductase |
Smith-Lemli-Opitz syndrome [MIM 270400] |
|
DPAGT1 |
dolichyl-phosphate (UDP-N-acetylglucosamine) N- GlcNAc-1-P transferase |
Congenital Disorders of Glycosylation [MIM 608093] |
|
DPM1 |
dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit |
Congenital disorder of glycosylation, type Ie [MIM 608799] |
|
EBP |
emopamil binding protein (sterol isomerase) |
Chondrodysplasia punctata [MIM 302960] |
|
MPDU1 |
mannose-P-dolichol utilization defect 1 |
Congenital disorder of glycosylation, type If [MIM 609180] |
|
MPI |
mannose phosphate isomerase |
Carbohydrate-deficient glycoprotein, type Ib [MIM 602579] |
|
PIGA |
phosphatidylinositol glycan anchor biosynthesis, class A |
Paroxysmal nocturnal hemoglobinuria [MIM 300818] |
|
PIGM |
phosphatidylinositol glycan anchor biosynthesis, class M |
Glycosylphosphatidylinositol deficiency [MIM 610293] |
|
PLOD1 |
procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1 |
Ehlers-Danlos syndrome, type VI [MIM 225400], Nevo syndrome [MIM 601451] |
|
PLOD2 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 |
Bruck syndrome 2 [MIM 609220] |
|
PLOD3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
Lysyl hydroxylase 3 deficiency [MIM 612394] |
|
PMM2 |
Phosphomannomutase 2 |
Congenital disorder of glycosylation, type Ia [MIM 212065] |
|
REEP1 |
Receptor Expression-Enhancing Protein 1 |
Spastic paraplegia 31 [MIM 610250], Spastic paraplegia-3A [MIM 182600] |
|
SAR1B |
SAR1 homolog B (S. cerevisiae) |
Chylomicron retention disease [MIM 246700] |
|
SEC23A |
Sec23 homolog A (S. cerevisiae) |
Craniolenticulosutural dysplasia [MIM 607812] |
|
SEC23B |
Sec23 homolog B (S. cerevisiae) |
Congenital dyserythropoietic anemia type II [MIM 224100] |
|
SLC35D1 |
Solute carrier family 35, D1 (UDP-glucuronic acid/UDP-N-acetylgalactosamine transport |
Schneckenbecken dysplasia [MIM 269250] |
|
SPAST |
Spastin |
Spastic paraplegia-4 [MIM 604277] |
|
SPTLC1 |
serine palmitoyltransferase, long chain base subunit 1 |
Neuropathy, hereditary sensory and autonomic, type 1 [MIM 162400] |
|
SUMF1 |
sulfatase modifying factor 1 |
Multiple sulfatase deficiency [MIM 272200] |
|
TMEM15 |
dolichol kinase |
Congenital Disorders of Glycosylation [MIM 610768] |
|
TRAPPC2 |
trafficking protein particle complex 2 |
Spondyloepiphyseal dysplasia tarda [MIM 313400] |
Golgi |
ARFGEF2 |
ADP-ribosylation factor GEF 2 |
Periventricular heterotopia, microcephaly [MIM 608097] |
|
ATP7A |
ATPase, Cu++ transporting, alpha polypeptide |
Menkes disease [MIM 309400], Occipital horn syndrome [MIM 304150] |
|
ATP7B |
ATPase, Cu++ transporting, beta polypeptide |
Wilson disease [MIM 277900] |
|
B3GALTL |
beta 1,3-galactosyltransferase-like |
Peters-plus syndrome [MIM 261540] |
|
B4GALT1 |
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
Congenital Disorders of Glycosylation [MIM 607091] |
|
B4GALT7 |
xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I) |
Ehlers-Danlos syndrome, progeroid form [MIM 130070] |
|
CHST3 |
carbohydrate (chondroitin 6) sulfotransferase 3 |
Spondyloepiphyseal dysplasia, Omani type [MIM 143095] |
|
CHST6 |
carbohydrate (N-acetylglucosamine 6-O) sulfotransferase 6 |
Macular corneal dystrophy [MIM 217800] |
|
COG1 |
component of oligomeric golgi complex 1 |
Congenital disorder glycosylation, type IIg [MIM 611209] |
|
COG7 |
component of oligomeric golgi complex 7 |
Congenital disorder glycosylation, type IIe [MIM 608779] |
|
COG8 |
component of oligomeric golgi complex 8 |
Congenital disorder glycosylation, type IIh [MIM 611182] |
|
DYM |
dymedin |
Dyggve-Melchior-Clausen disease [MIM 223800], Smith-McCort dysplasia [MIM 607326] |
|
FGD1 |
FYVE, RhoGEF PH domain containing 1 |
Aarskog-Scott syndrome [MIM 305400] |
|
GALNT3 |
UDP-N-acetyl-alpha-D- GalNAc-transferase, T3 |
Tumoral calcinosis, hyperphosphatemic [MIM 211900] |
|
GNPTAB |
N-acetylglucosamine-1-phosphate transferase, alpha and beta subunits |
Mucolipidosis III alpha/beta [MIM 252600], Mucolipidosis II alpha/beta [MIM 252500] |
|
INPP5E |
Inositol polyphosphate-5-phosphatase, 72-KD |
Mental retardation, retinal dystrophy [MIM 610156], Joubert syndrome [MIM 213300] |
|
LFNG |
LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase |
Spondylocostal dysostosis, [MIM 609813] |
|
LMAN1 |
lectin, mannose-binding, 1 |
Combined factor V and VIII deficiency [MIM 227300] |
|
MCFD2 |
multiple coagulation factor deficiency 2 |
Combined factor V and VIII deficiency [MIM 613625] |
|
MGAT2 |
mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase |
Carbohydrate-deficient glycoprotein syndrome, type II [MIM 212066] |
|
PAPSS2 |
3'-phosphoadenosine 5'-phosphosulfate synthase 2 |
Spondyloepimetaphyseal dysplasia [MIM 612847] |
|
POMGNT1 |
protein O-linked mannose beta1,2-N-acetylglucosaminyltransferase |
Muscle-eye-brain disease [MIM 253280] |
|
POMT1 |
protein-O-mannosyltransferase 1 |
Walker-Warburg syndrome [MIM 236670], Muscular dystrophy, [MIM 236670] |
|
POMT2 |
protein-O-mannosyltransferase 2 |
Walker-Warburg syndrome [MIM 236670] |
|
PSEN1 |
presenilin 1 |
Alzheimer disease, [MIM 607822], Dementia, frontotemporal [MIM 600274], Pick disease [MIM 172700] |
|
PSEN2 |
presenilin 2 (Alzheimer disease 4) |
Alzheimer disease-4 [MIM 606889] |
|
SCYL1BP1 |
SCYL1-binding protein 1 |
Gerodermia osteodysplastica [MIM 231070] |
|
SIAT9 |
SIALYLTRANSFERASE 9 |
AMISH Infantile Epilepsy Syndrome [MIM 609056] |
|
SLC26A2 |
Solute carrier family 26 (sulfate transporter), member 2 |
Achondrogenesis type IB [600972] |
|
STXBP2 |
syntaxin binding protein 2 |
Hemophagocytic lymphohistiocytosis, familial, 5 |
|
TRIP11 |
thyroid hormone receptor interactor 11 GMAP 210 Golgin Microtubue associated Protein |
Achondrogenesis type 1A [MIM 200600] |
|
XYLT1 |
xylosyltransferase I |
Pseudoxanthoma elasticum, modifier of severity of [MIM 264800] |
|
XYLT2 |
xylosyltransferase II |
Pseudoxanthoma elasticum, modifier of severity of [MIM 264800] |
EN/LY |
AGA |
Glycosylasparaginase |
Aspartylglucosaminuria [MIM208400] |
|
AP3B1 |
AP3 beta-subunit |
Hermansky Pudlak 2 [MIM 608233] |
|
ARSA |
Arylsulfatase A |
Metachromatic leukodystrophy [MIM 607574] |
|
ARSB |
N-acetylgalactosamine 4-sulfatase |
Maroteaux-Lamy MIM [253200] |
|
ASAH1 |
Acid ceramidase |
Farber lipogranulomatosis [MIM 228000] |
|
ATP6AP2 |
ATPase, H+ transporting, lysosomal accessory protein 2 |
Mental retardation, X-linked, with epilepsy [MIM 300423] |
|
ATP6V0A2 |
ATPase, H+ transporting, lysosomal V0 subunit a2 |
Cutis laxa, autosomal recessive, type II [MIM 219200], Wrinkly skin syndrome [MIM 278250] |
|
ATP6V0A4 |
ATPase, H+ transporting, lysosomal V0 subunit a4 |
Renal tubular acidosis, distal, autosomal recessive [MIM 602722] |
|
BIN1 |
bridging integrator 1, synaptophysin |
Myopathy centronuclear [MIM 255200] |
|
BLOC1S3 |
BiogenesisLysosomalOrganellesComplex-1S3 |
Hermansky-Pudlak syndrome 8 [MIM 203300] |
|
CLCN2 |
chloride channel 2 |
Epilepsy [MIM 607628] |
|
CLCN5 |
chloride channel 5 |
Dent disease [MIM 300009] |
|
CLCNKB |
chloride channel Kb |
Bartter syndrome, type 3 [MIM 607364] |
|
CLN3 |
Ceroid lipofuscinosis, neuronal, 3 |
Ceoid lipofuscinosis 3 [MIM 204200] |
|
CTNS |
cystinosis, nephropathic |
Cystinosis, [MIM 219800] |
|
CTSA |
Cathepsin A |
Galactosialidosis [MIM 256540] |
|
CTSC |
Cathepsin C |
Papillon-Lefevre syndrome [MIM 245000], Haim-Munk syndrome [MIM 245010] |
|
CTSD |
Cathepsin D |
Ceroid lipofuscinosis, neuronal, 10 [MIM 610127] |
|
CTSK |
Cathepsin K |
Pycnodysostosis [265800] |
|
DTNBP1 |
dystrobrevin binding protein 1 |
Hermansky-Pudlak syndrome 7 [MIM 203300] |
|
FGD4 |
FYVE, RhoGEF and PH domain containing |
Charcot-Marie-Tooth disease, type 4H [MIM 609311] |
|
FIG4 |
FIG4 homolog (S. cerevisiae) |
Charcot-Marie-Tooth disease, type 4J [MIM 611228], Amyotrophic lateral sclerosis 11 [MIM 612577] |
|
FUCA1 |
Fucosidase |
Fucosidosis [MIM 230000] |
|
GAA |
alpha-glucosidase |
Pompe disease [MIM 232300] |
|
GALC |
beta-galactosylceramidase |
Krabbe disease [MIM 245200] |
|
GALNS |
galactosamine (N-acetyl)-6-sulfate sulfatase |
MPS IVA [MIM 253000] |
|
GBA |
glucosidase, beta, acid |
Gaucher disease [MIM 230800] |
|
GLA |
alpha-galactosidase |
Fabry disease [MIM 301500] |
|
GLB1 |
beta -galactosidase |
GM1 gangliosidosis [MIM230500] |
|
GM2A |
GM2 activator protein |
GM2 gangliosidosis [MIM272750] |
|
GNS |
N-acetylglucosamine 6-sulfatase |
MPSIIID [MIM252940] |
|
GUSB |
beta-glucuronidase |
MPSVII [MIM 253220] |
|
HEXA |
beta-Hexosaminidase, alpha-subunit |
Tay-Sachs disease [MIM 272800] |
|
HEXB |
beta-Hexosaminidase, beta-subunit |
Sandhoff disease [MIM 268800] |
|
HGSNAT |
Acetyl-coA transferase |
MPSIIIC [MIM 252930] |
|
HYAL1 |
Hyaluronidase |
MPSIX [MIM 601492] |
|
IDS |
Iduronate sulfatase |
MPS II [MIM 309900] |
|
IDUA |
alpha-iduronidase |
MPSI [MIM 607015] |
|
LAMP-2 |
Lysosome-associated membrane protein 2 |
Danon disease [MIM 300257] |
|
LIPA |
Acid lipase |
Wolman and cholesteryl ester storage storage disease [MIM 278000] |
|
LYST |
lysosomal trafficking regulator |
Chediak-Higashi syndrome [MIM 214500] |
|
MAN2B1 |
alpha-Mannosidase |
alpha-mannidosis [MIM248500] |
|
MANBA |
beta -mannosidase |
beta-mannosidosis [MIM248510] |
|
MCOLN1 |
Mucolipin 1 |
Mucolipidosis IV [MIM 252650] |
|
GNPTAG |
UDP-N-acetylglucosamine phosphotransferase gamma-subunit |
Mucolipidosis III [MIM 252605] |
|
MLPH |
Melanophilin |
Griscelli syndrome type 3 [MIM 609227] |
|
MTM1 |
myotubularin 1 |
Myotubular myopathy, X-linked [MIM 310400] |
|
MTMR2 |
myotubularin related protein 2 |
Charcot-Marie-Tooth disease, type 4B1 [MIM 601382] |
|
MYO5A |
myosin VA (heavy chain 12, myoxin) |
Griscelli syndrome, type 1 [MIM 214450] |
|
MYO5B |
myosin VB |
Microvillus inclusion disease [MIM 251850] |
|
NAGA |
alpha-N-Acetylglucosaminidase |
Schindler [MIM 104170] |
|
NAGLU |
N-acetylglucosaminidase |
MPSIIIB [MIM 252920] |
|
NEU |
beta-sialidase |
Sialidosis [MIM 256550] |
|
NPC1 |
Niemann-Pick disease type C I |
Niemann-Pick disease type C I [MIM 257220] |
|
NPC2 |
Niemann-Pick disease type C I |
Niemann-Pick disease type C 2 [MIM 607625] |
|
OCRL |
oculocerebrorenal syndrome of Lowe |
Lowe syndrome [MIM 309000], Dent 2 [MIM 300555] |
|
PPT1 |
Tripeptidyl peptidase |
Ceroid lipofuscinosis 2 [MIM 600722] |
|
PSAP |
Saposin C |
Gaucher disease [MIM 249900] |
|
PSAP |
Prosaposin B |
Metachromatic leukodystrophy [MIM 249900] |
|
RAB23 |
RAB23, member RAS oncogene family |
Carpenter syndrome [MIM 201000] |
|
RAB27A |
RAB27A, member RAS oncogene family?* |
Griscelli syndrome, type 2 [MIM 607624] |
|
SBF2 |
SET binding factor 2 |
Charcot-Marie-Tooth disease, type 4B2 [MIM 604563] |
|
SGSH |
Heparan N-sulfatase |
MPSIIIA [MIM 252900] |
|
SH3TC2 |
SH3 domain and tetratricopeptide repeats 2 |
Charcot-Marie-Tooth disease, type 4C [MIM 601596] |
|
SLC17A5 |
Sialin |
Salla disease [MIM 604369] |
|
SMPD1 |
Acid phingomyelinase |
Niemann-Pick type A and B [MIM 257200], [MIM 607616] |
|
SNAP29 |
synaptosomal-associated protein, 29kDa |
Cerebral dysgenesis, neuropathy, ichthyosis, [MIM 609528] |
|
SPG20 |
spastic paraplegia 20 (Troyer syndrome) |
Troyer syndrome [MIM 275900] |
|
TPP1 |
Palmitoyl-protein thioesterase |
Ceorid lipofuscinosis 1 [MIM 607998], Periodontitis [MIM 170650] |
|
TYR |
tyrosinase (oculocutaneous albinism IA) |
Albinism, oculocutaneous, [MIM 203100] |
|
TYRP1 |
tyrosinase-related protein 1 |
Albinism, brown [MIM 203290] |
MIT |
ABC7 |
ATP-binding cassette 7 |
Sideroblatic anemia [MIM 301310] |
|
ATPAF2 |
ATP synthase, mitochondrial F1 complex assembly factor 2 |
Mitochondrial complex V deficiency [MIM 604273] |
|
BCS1L |
BCS1, S. cervisae homolog-like |
Mitochondrial complex III deficiency [MIM 124000] |
|
COX10 |
cytochrome c oxidase (COX) assembly protein 10 |
Encephalopathy, progressive mitochondrial, with proximal renal tubulopathy due to cytochrome c oxidase deficiency [MIM 602125] |
|
COX15 |
cytochrome c oxidase (COX) assembly protein 15 |
Leigh syndrome due to cytochrome c oxidase deficiency [MIM 256000] |
|
DDP |
Translocase of inner mitochondrial membrane 8 |
Deafness Jensen syndrome [MIM 311150], Mohr-Tranebjaerg [MIM 304700] |
|
DGUOK |
deoxyguanosine kinase |
Mitochondrial DNA depletion syndrome [MIM 251880], Metaphyseal dysplasia without hypotrichosis [MIM 250460] |
|
ECGF1 |
Thymidine phosphorylase |
Mitochondrial DNA depletion syndrome 1 (MNGIE type) [MIM 603041] |
|
ETHE1 |
ETHE1 |
Ethylmalonic encephalopathy [MIM 602473] |
|
FRDA |
Frataxin |
Friederich ataxia [MIM 229300] |
|
G4.5 |
Tafazzin |
Barth syndrome [MIM 302060] |
|
GFM1 |
Mitochondrial elongation factor G1 |
Combined oxidative phophorylation deficiency 1 [MIM 609060] |
|
LRPPRC |
Leucine-rich PPR motif-containing protein |
Leigh syndrome, French-Canadian type [MIM 220111] |
|
MPV17 |
MPV17 |
MITOCHONDRIAL DNA DEPLETION Sybdrome 6 [MIM 256810] |
|
NDUFAF2 |
NADH:ubiquinone oxidoreductase assembly factor 2 |
Mitochondrial complex I deficiency [MIM252010] |
|
NDUFS1 |
NADH:ubiquinone oxidoreductase Fe-S protein 1 |
Mitochondrial complex I deficiency [MIM 252010] |
|
NDUFS2 |
NADH:ubiquinone oxidoreductase Fe-S protein 2 |
Mitochondrial complex I deficiency [MIM 252010] |
|
NDUFS3 |
NADH:ubiquinone oxidoreductase Fe-S protein 3 |
Mitochondrial complex I deficiency [MIM 252010] |
|
NDUFS7 |
NADH:ubiquinone oxidoreductase Fe-S protein 7 |
Mitochondrial complex I deficiency [MIM 252010] |
|
NDUFS8 |
NADH:ubiquinone oxidoreductase Fe-S protein 8 |
Mitochondrial complex I deficiency [MIM 252010] |
|
NDUFV1 |
NADH:ubiquinone oxidoreductase flavoprotein 1 |
Mitochondrial complex I deficiency [MIM 252010] |
|
NDUFV2 |
NADH:ubiquinone oxidoreductase flavoprotein 2 |
Mitochondrial complex I deficiency [MIM 251010] |
|
PDHA |
Pyruvate dehydrogenase, subunit A |
Pyruvate dehydrogenase deficiency [MIM 312170] |
|
POLG |
Polymerase, DNA, Gamma |
Mitochondrial DNA depletion syndrome 4A (Alpers type) [MIM 203700], Mitochondrial DNA depletion syndrome 4B (MNGIE type) [MIM 613662], Mitochondrial recessive ataxia syndrome [MIM 607459], Progressive external ophthalmoplegia, autosomal dominant [MIM 157640], Progressive external ophthalmoplegia, autosomal recessive [MIM 258450] |
|
RMRP |
Mitochondrial RNA-processing endoribonuclease |
Anauxetic dysplasia [MIM 607095], Cartilage-hair hypoplasia [MIM 250250] |
|
RRM2B |
Ribonucleotide Reductase M2 B |
Mitochondrial DNA depletion syndrome 8 [MIM 612075], Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant, 5 [MIM 613077] |
|
SCO1 |
Cytochrome oxidase deficient 1, S. cervisae homolog of |
Hepatic failure and neurologic disorder [603644] |
|
SCO2 |
SCO2, S. cervisae homolog of |
Cardioencephalomyopathy, fatal infantile, due to cytochrome c oxidase deficiency [MIM 604377] |
|
SDH-A |
succinate dehydrogenase, subunit A |
Mitochondrial complex II deficiency [MIM 252011] |
|
SPG7 |
Paraplegin ATPase protease |
Spastic paraplegia [MIM 607259] |
|
SURF1 |
Surfeit 1 |
Leigh syndrome and COX deficiency [MIM 256000] |
|
TK2 |
Thymidine kinase-2 |
Mitochondrial DNA depletion syndrome [MIM 609560] |
|
UQCRB |
ubiquinol-cytochrome c oxidoreductase |
Mitochondrial complex III deficiency [MIM 124000] |
PEX |
PEX1 |
Peroxisome biogenesis factor 1 |
Zellweger syndrome [MIM214100], Infantile Refsum disease [MIM 266510] |
|
PEX2 |
Peroxisome biogenesis factor 2 |
Zellweger syndrome [MIM214100], Infantile Refsum disease [MIM 266510] |
|
PEX3 |
Peroxisome biogenesis factor 3 |
Zellweger syndrome [MIM214100], Neonatal adrenoleukodystrophy [MIM 202370] |
|
PEX5 |
Peroxisome biogenesis factor 5 |
Zellweger syndrome [MIM214100], Neonatal adrenoleukodystrophy [MIM 202370] |
|
PEX6 |
Peroxisome biogenesis factor 6 |
Zellweger syndrome [MIM214100] |
|
PEX12 |
Peroxisome biogenesis factor 12 |
Zellweger syndrome [MIM214100] |
|
PEX14 |
Peroxisome biogenesis factor 14 |
Zellweger syndrome [MIM214100] |
|
PEX26 |
Peroxisome biogenesis factor 26 |
Zellweger syndrome [MIM214100], Infantile Refsum disease [MIM 266510] |
|
PEX10 |
Peroxisome biogenesis factor 10 |
Neonatal adrenoleukodystrophy [MIM 202370] |
|
PEX13 |
Peroxisome biogenesis factor 13 |
Neonatal adrenoleukodystrophy [MIM 202370], Neonatal adrenoleukodystrophy [MIM 202370] |
|
PEX7 |
Peroxisome biogenesis factor 7 |
Rhizomelic chondrodysplasia punctata [MIM 215100] |
|
PHYH |
Phytanoyl-CoA hydroxylase |
Pipecolic acidemia [MIM 600964], Refsum disease [MIM 266500] |
|
AGXT |
Alanine:glyoxylate aminotransferase |
Primary hyperoxaluria type 1 [MIM 259900] |
|
ACOX1 |
Acetyl-coA oxidase |
Acyl-coA oxidase deficiency [MIM 264470] |
|
HSD17B4 |
Bifunctional protein |
Bifunctional protein deficiency [MIM 261515] |
|
GNPAT |
Dihydroxyacetonephosphate acyltransferase |
Dihydroxyacetonephosphate acyltransferase deficiency [MIM 222765] |
|
ABCD1 |
ATP-binding cassette, subfamily D, member 1 |
X-linked adrenoleukodytrophy [MIM 300100] |
|
AMACR |
alpha-Methylacyl-CoA racemase |
alpha-Methylacyl-CoA racemase deficiency [MIM 614307] |
|
DHAPAT |
Dihydroxyacetonephosphate acyltransferase |
Rhizomelic chondrodysplasia punctata type 2 [MIM 222765] |
|
AGPS |
Alkyl-DHAP synthase |
Rhizomelic chondrodysplasia punctata type 3 [MIM 600121] |
NL |
LBR |
lamin B receptor |
HEM skeletal dysplasia [MIM 215140], Pelger-Huet anomaly [MIM 169400] |
|
EMD |
Emerin |
Emery-Dreifuss muscular dystrophy-1 [MIM 310300] |
|
LMNA |
Lamin A/C |
Charcot-Marie-Tooth disease, type 2B1 [MIM 605588], Mandibuloacral dysplasia type A with partial lipodystrophy [MIM 248370] |
|
ZMPSTE24 |
zinc metalloproteinase 24 |
Mandibuloacral dysplasia with type B lipodystrophy [MIM 608612] |
Cilia |
AHI1 |
Abelson helper integration site 1 |
Joubert syndrome [MIM 608629] |
|
BBS1 |
Bardet-Biedl syndrome-1 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS10 |
Bardet-Biedl syndrome-10 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS11 |
Bardet-Biedl syndrome-11 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS12 |
Bardet-Biedl syndrome-12 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS14 |
Bardet-Biedl syndrome-15 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS2 |
Bardet-Biedl syndrome-2 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS3 |
Bardet-Biedl syndrome-3 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS4 |
Bardet-Biedl syndrome-4 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS5 |
Bardet-Biedl syndrome-5 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS6 |
Bardet-Biedl syndrome-6 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS7 |
Bardet-Biedl syndrome-7 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS8 |
Bardet-Biedl syndrome-8 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
BBS9 |
Bardet-Biedl syndrome-9 |
BARDET-BIEDL Syndrome [MIM 209900] |
|
CC2D2A |
Coiled-coil and C2 domains containing protein 2A |
COACH Syndrome [MIM 216360], JOUBERT Syndrome [MIM 612285], LEBER Congenital Amaurosis [MIM 611755] , MECKEL Syndrome Type 4 [MIM 611134], SENIOR-LOKEN Syndrome [MIM 610189] |
|
CEP290 |
Centrosomal protein, 290-KD |
BARDET-BIEDL Syndrome [MIM 209900], JOUBERT Syndrome [MIM 610188] |
|
DNAH11 |
Dynein axonemal heavy chain 11 |
Primary ciliary dyskinesia [MIM 611884] |
|
DNAH5 |
Dynein axonemal heavy chain 5 |
Primary ciliary dyskinesia [MIM 608644] |
|
DNAI1 |
Dynein axonemal intermediate chain 1 |
Primary ciliary dyskinesia [MIM 244400], Reynolds Syndrome [MIM 613471] |
|
DNAI2 |
Dynein axonemal intermediate chain 2 |
Primary ciliary dyskinesia [MIM 612444] |
|
MKS1 |
Meckel syndrome-1 |
BARDET-BIEDL Syndrome [MIM 209900], MECKEL Syndrome Type 1 [MIM 249000] |
|
NPHP1 |
Nephrocystin 1 |
JOUBERT Syndrome [MIM 609583], NEPHRONOPHTHISIS 1 [MIM 256100], MECKEL Syndrome Type 6 [MIM 612284] |
|
NPHP2 |
Nephrocystin 2 |
NEPHRONOPHTHISIS 2 [MIM 602088] |
|
NPHP3 |
Nephrocystin 3 |
MECKEL Syndrome Type 7 [MIM 267010], NEPHRONOPHTHISIS 3 [MIM 604387], SENIOR-LOKEN Syndrome 1 [MIM 266900], RENAL-HEPATIC-PANCREATIC Dysplasia [MIM 208540] |
|
NPHP4 |
Nephrocystin 4 |
NEPHRONOPHTHISIS 4 [MIM 606966] |
|
NPHP5 |
Nephrocystin 5 |
SENIOR-LOKEN Syndrome 5 [MIM 609254] |
|
NPHP7 |
Nephrocystin 7 |
NEPHRONOPHTHISIS 7 [MIM 611498] |
|
NPHP9 |
Nephrocystin 9 |
NEPHRONOPHTHISIS 9 [MIM 613824] |
|
OFD1 |
Orofaciodigital syndrome type 1 |
Orofaciodigital syndrome type 1 [MIM 311200] |
|
PKHD1 |
Polycystic kidney and hepatic disease-1 |
Polycystic kidney [MIM 263200], MECKEL Syndrome Type 5 [MIM 611561] |
|
RPGRIP1L |
RPGRIP1-like |
COACH Syndrome [MIM 216360], JOUBERT Syndrome [MIM 611560], MECKEL Syndrome Type 3 [MIM 607361], NEPHRONOPHTHISIS 11 [MIM 613550] |
|
RSPH4A |
Radial spoke head 4 |
Primary ciliary dyskinesia [MIM 612649] |
|
RSPH9 |
Radial spoke head 9 |
Primary ciliary dyskinesia [MIM 612650] |
|
TMEM237 |
Transmembrane protein 237 |
JOUBERT Syndrome [ MIM 614224] |
|
TMEM67 |
Transmembrane protein 67 |
COACH Syndrome [MIM 216360], JOUBERT Syndrome [MIM 610688] |
|
TXNDC3 |
Thioredoxin domain-containing protein 3 |
Primary ciliary dyskinesia [MIM 610852] |